Despite decades of widespread awareness, vitamin D deficiency remains one of the most prevalent nutritional shortfalls in the world — affecting an estimated 47 per cent of the global population, including many who live in sunny climates and consider themselves broadly healthy. The reason is not simply a lack of sunlight. It is that the relationship between sun exposure and vitamin D production is far more limited and unreliable than most people assume, and that the consequences of sustained insufficiency touch nearly every system in the body. Understanding what vitamin D does, why levels fall short so readily, and how to address that gap is a genuinely worthwhile investment in long-term health.

What Is Vitamin D and Why Does It Matter?

Vitamin D occupies an unusual position among nutrients: though classified as a vitamin, it functions in the body more like a hormone, binding to receptors in tissues throughout the body and influencing the expression of hundreds of genes. Its most established role is in calcium metabolism — without adequate vitamin D, the gut cannot absorb calcium efficiently, and the skeleton cannot maintain its structural integrity. But its reach extends considerably further than bone.

Vitamin D supports immune cell function, modulating both the innate response to infection and the adaptive mechanisms that underlie long-term immunity. It plays a role in muscle fibre contractility and neuromuscular coordination, which becomes clinically significant in older adults where deficiency is associated with increased fall risk and reduced physical performance. Low levels have been consistently linked to fatigue, low mood, and impaired cognitive function — associations robust enough to have prompted clinical interest in vitamin D as a contributor to seasonal affective disorder. More broadly, research suggests a relationship between sustained deficiency and elevated risk of cardiovascular disease, autoimmune conditions, and certain metabolic disorders, though the direction of causality in some of these associations remains a subject of active investigation.

Vitamin D is obtained in three ways: synthesised in the skin from UVB radiation, consumed through a small number of foods (notably oily fish, egg yolks, and fortified products), and taken as a supplement or injection. In practice, the first route is far less dependable than is commonly appreciated, and the second rarely provides sufficient quantities without deliberate effort. For most people, supplementation represents the most reliable means of maintaining adequate levels.

Why Sunlight Alone Is Insufficient

The intuition that sunlight reliably provides vitamin D is understandable, but the evidence does not support it. A 2025 global meta-analysis of over 1.5 million participants found that nearly half the world’s population had vitamin D insufficiency despite varied climates and sun exposure patterns. Deficiency rates remain high in the Middle East, in sun-rich countries of South Asia, and in Australia, where winter levels fall below the sufficiency threshold in up to 36 per cent of the population.

The practical limitations of sun-based synthesis are numerous. UVB radiation sufficient to produce vitamin D is only available at certain times of day, at certain latitudes, and during certain seasons. Skin pigmentation, sunscreen use, clothing, age-related decline in skin synthesis capacity, and the simple reality of indoor working lives all reduce production substantially. In a controlled trial of Korean adults with established deficiency, four weeks of midday sun exposure three times per week raised vitamin D levels by less than 1 ng/mL, while a daily supplement of 800 IU produced nearly four times the improvement. Critically, major dermatological and oncology bodies now explicitly advise against deliberate unprotected UV exposure as a vitamin D strategy, given that the risk of skin damage and skin cancer outweighs the modest and unreliable benefit.

The practical conclusion is straightforward: for most people, and particularly those living in cities, working indoors, or using sun protection consistently — as they should — sunlight cannot be relied upon as a meaningful source of vitamin D. Supplementation is not a workaround; it is the appropriate primary strategy.

Recognising Vitamin D Deficiency

Vitamin D deficiency is frequently silent, particularly in its earlier stages. When symptoms do present, they are often non-specific and easily attributed to other causes, which is why testing rather than symptom-based diagnosis is essential. The most common presentations include persistent fatigue and low energy that does not resolve with rest, low mood or a generalised sense of reduced wellbeing, and diffuse musculoskeletal discomfort — a deep aching in the bones and muscles, particularly in the lower limbs, that patients sometimes describe as heaviness or a reluctance to climb stairs. Muscle weakness, reduced exercise tolerance, and more frequent falls in older adults are also associated with deficiency, as is impaired wound healing and a susceptibility to recurrent infections.

In more prolonged or severe deficiency, bone mineralisation is affected. In adults, this manifests as osteomalacia — a softening of the bones that produces pain and, in its milder form, is sometimes mistaken for general musculoskeletal symptoms. Stress fractures occurring with minor trauma may also signal significantly depleted stores. In children, severe deficiency causes rickets, characterised by skeletal deformities, delayed growth, and irritability — a condition that, while rare in well-nourished populations, remains relevant where dietary intake and sun exposure are both limited. None of these symptoms are specific to vitamin D alone, and a blood test is the only reliable way to confirm deficiency.

Who Should Be Tested and When

Routine vitamin D screening of all healthy adults without symptoms or risk factors is not universally recommended, as the clinical yield is low in low-risk populations. Testing is, however, clearly appropriate for individuals with symptoms suggestive of deficiency, those with established risk factors, and anyone commencing or adjusting therapeutic doses of supplementation or injection therapy. The relevant blood test measures 25-hydroxyvitamin D, written as 25(OH)D, which represents the body’s stored form and is the most accurate reflection of overall vitamin D status.

Risk factors that warrant testing include limited sun exposure due to indoor work, consistent sunscreen or clothing coverage, or residence at higher latitudes; darker skin tone, which reduces UVB-driven synthesis; older age, where skin synthesis capacity declines significantly; pregnancy and breastfeeding, both of which increase demand; obesity, as vitamin D is sequestered in adipose tissue and less available to the circulation; conditions affecting fat absorption such as coeliac disease, inflammatory bowel disease, or previous bariatric surgery; chronic liver or kidney disease, which impairs the conversion of vitamin D to its active form; and the use of medications known to interfere with vitamin D metabolism, including anticonvulsants, glucocorticoids, and certain antiretroviral agents.

Once supplementation or injection therapy has begun, re-testing after eight to twelve weeks allows assessment of the response, as vitamin D equilibrates slowly in the body. For those on higher or ongoing doses, periodic monitoring — every six to twelve months — ensures levels remain within the appropriate range and avoids the small but real risk of over-supplementation.

Interpreting Your 25(OH)D Result

25(OH)D Level	Interpretation	Recommended Action
Below 12 ng/mL(below 30 nmol/L)	Deficiency	Treatment indicated; investigate underlying cause
12–19 ng/mL(30–49 nmol/L)	Insufficiency	Supplement and re-test in 8–12 weeks
20–40 ng/mL(50–100 nmol/L)	Adequate for most adults	Maintain with appropriate supplementation; personalise to risk profile
41–60 ng/mL(100–150 nmol/L)	Above routine targets	Review dose unless specifically indicated by a clinician
Above 150 ng/mL(above 375 nmol/L)	Potential toxicity	Urgent clinical review; assess calcium and kidney function

Oral Vitamin D Supplements

Oral supplementation is the most practical and widely accessible means of correcting and maintaining vitamin D levels for the majority of individuals. Supplements are available as tablets, capsules, and liquid drops, and are effective when taken consistently. For most adults, a daily dose of 800 to 2,000 IU is appropriate for maintenance, though those with established deficiency or specific clinical needs may be advised to take higher doses under medical supervision for an initial correction period before stepping down to a maintenance level.

Vitamin D2 versus Vitamin D3

Two forms of vitamin D are available in supplements: vitamin D2, known as ergocalciferol, and vitamin D3, known as cholecalciferol. Both are converted in the liver to 25(OH)D — the form measured in blood tests — and then further activated in the kidneys to the hormonal form that exerts effects throughout the body. Their metabolic pathways are broadly similar, but they differ in one practically important respect.

Vitamin D3 binds more tightly to vitamin D–binding protein in the blood, giving it a longer half-life and producing higher and more sustained 25(OH)D levels per unit of dose than D2 in most head-to-head studies. For the majority of adults, D3 is the more efficient choice: it raises levels more reliably and maintains them more consistently between doses. Vitamin D2 remains entirely clinically acceptable — it was, for many years, the primary prescription form and continues to be used effectively — but achieving equivalent results typically requires a somewhat higher total weekly dose or more frequent dosing intervals. For individuals following a strict vegan diet, D2 is derived from plant and yeast sources and is therefore suitable; vegan-sourced D3, produced from algae or lichen rather than the more common lanolin, is now also widely available and represents an equally plant-based option.

Laboratory reports measuring 25(OH)D sometimes break out the D2 and D3 fractions separately. This is a feature of the assay rather than cause for concern — clinicians assess the total combined value, and the individual fractions are rarely of clinical significance in routine supplementation.

Feature	Vitamin D2 (Ergocalciferol)	Vitamin D3 (Cholecalciferol)
Source	Plant and yeast sterols; vegan-suitable	Lanolin (sheep’s wool); vegan D3 from algae/lichen also available
Relative potency per IU	Modestly lower	Higher — raises and sustains 25(OH)D more efficiently
Half-life in the body	Shorter	Longer — maintains levels better between doses
Common forms available	Prescription 50,000 IU capsules; some OTC products	Widely available OTC at 1,000–5,000 IU daily; weekly and monthly formats
Best suited to	Strict vegans; where prescription coverage applies	Most adults as default choice
Both safe at standard doses?	Yes	Yes — same toxicity profile

Vitamin D Injections

For individuals who cannot absorb oral vitamin D reliably — due to inflammatory bowel disease, coeliac disease, bariatric surgery, or other conditions affecting fat absorption — or for those in whom consistent daily supplementation is impractical, intramuscular injection offers a compelling alternative. A single injection of 300,000 IU delivers a large depot dose directly into the muscle, from which vitamin D is released gradually into the circulation over weeks to months. The effect is prolonged, and the administration is performed once rather than requiring daily adherence.

Injections are also appropriate where deficiency is severe and rapid correction is a clinical priority, or where a patient has previously failed to achieve adequate levels through oral supplementation alone. As with all high-dose vitamin D approaches, a baseline blood test is essential before administration, and a follow-up test at eight to twelve weeks confirms the response and guides decisions about whether maintenance supplementation or a further injection is indicated. Injections are administered by a healthcare professional and should not be repeated without clinical assessment, as the prolonged depot effect means that any excess accumulates over time.

Safety and the Question of Excess

Vitamin D toxicity is uncommon in clinical practice but is a real consideration with high-dose or injection-based approaches, which is why professional guidance and monitoring are essential. Toxicity does not arise from diet or sun exposure; it is caused by the sustained ingestion of very high supplementary doses over time. The primary consequence is hypercalcaemia — elevated calcium in the blood — which at significant levels causes nausea, confusion, excessive thirst, kidney stones, and, in severe cases, organ damage.

For most adults on standard maintenance doses of 800 to 2,000 IU daily, the risk of toxicity is negligible. The tolerable upper intake level established by regulatory bodies is generally set at 4,000 IU per day for adults, though clinical protocols for deficiency correction may use higher doses for defined periods under supervision. The threshold for toxicity in blood testing — broadly, a 25(OH)D level above 150 ng/mL — is well above the range that appropriate supplementation produces. The sensible approach is to test, supplement to a defined target, and monitor periodically rather than to supplement indefinitely without oversight.

Frequently Asked Questions

I live somewhere sunny. Do I still need to worry about vitamin D?

Quite possibly, yes. Research consistently shows that deficiency is common even in populations with high year-round sun exposure, including those in the Middle East, South Asia, and tropical regions. Sunscreen use, clothing, indoor working, skin pigmentation, and the limited hours of optimal UVB availability all reduce synthesis substantially. Living in a sunny climate does not guarantee adequate vitamin D production, and a blood test is the only reliable way to know where your levels actually sit.

What is the difference between vitamin D2 and D3, and does it matter which I take?

Both forms raise vitamin D levels effectively. Vitamin D3 is generally the more efficient choice for most adults — it produces higher and more sustained blood levels per unit of dose and maintains them more consistently. Vitamin D2 is equally appropriate, particularly for those following a strict vegan diet, though achieving the same result may require slightly higher or more frequent dosing. For most people, D3 is a straightforward default; D2 is a sound alternative where dietary preference or prescription availability makes it the better option.

How do I know if I am deficient?

A blood test measuring 25(OH)D is the only reliable way to assess vitamin D status. Symptoms such as fatigue, bone aching, muscle weakness, and low mood are suggestive but non-specific — they overlap with many other conditions and cannot be used to confirm deficiency on their own. Testing is recommended for anyone with relevant symptoms or risk factors, and is essential before commencing high-dose supplementation or injection therapy.

How often should I take vitamin D, and in what dose?

For most adults, a daily dose of 800 to 2,000 IU is appropriate for ongoing maintenance. Those with established deficiency may be advised to take a higher corrective dose for an initial period — sometimes given as a weekly high dose rather than a daily one — before stepping down to maintenance. Injection therapy, typically at 300,000 IU, is given as a single administration and may last several months depending on the individual’s response. The appropriate dose for any individual should be guided by a blood test result and a clinician’s assessment rather than general guidance alone.

Is it possible to take too much vitamin D?

Yes, though toxicity from vitamin D is uncommon in practice and does not arise from sun exposure or standard dietary intake. It results from the sustained ingestion of very high supplementary doses, causing calcium to accumulate in the blood. The consequences at significant levels include nausea, confusion, kidney stones, and organ stress. Standard maintenance doses carry no meaningful risk of toxicity; higher therapeutic doses should always be used with professional monitoring and periodic blood testing to confirm that levels remain within the appropriate range.

Are vitamin D injections better than oral supplements?

They serve different purposes rather than representing a straightforward hierarchy. Oral supplements are effective, convenient, and appropriate for most people when taken consistently. Injections are most valuable where oral absorption is compromised, where daily adherence is not feasible, or where rapid correction of severe deficiency is a clinical priority. A single injection of 300,000 IU provides a sustained depot effect that removes the need for daily supplementation for several months. The choice between the two should be guided by individual circumstances and discussed with a clinician.

Can vitamin D improve my mood or energy levels?

There is reasonable evidence that correcting genuine deficiency improves mood, energy, and general wellbeing in those whose low levels are contributing to these symptoms. The relationship is most clearly supported in individuals with established insufficiency rather than those already within the normal range; supplementing further when levels are already adequate does not consistently produce additional benefit. If fatigue or low mood are among your concerns, a blood test to establish your current vitamin D status is a sensible first step, as it will clarify whether deficiency is a contributing factor worth addressing.

In Summary

Vitamin D is among the most clinically consequential nutritional considerations in modern preventive health — not because it is exotic, but because deficiency is so common, so frequently unrecognised, and so straightforwardly addressed once identified. Sunlight is an unreliable and impractical primary source for most people; oral supplementation and, where indicated, intramuscular injection are the safe and effective alternatives. The key to using them well lies in testing before commencing therapy, supplementing to a defined evidence-based target, and monitoring periodically to ensure levels remain appropriate over time.

A consultation with a qualified clinician ensures that your vitamin D status is assessed accurately, that the right form and dose are selected for your circumstances, and that any therapeutic programme is managed with the care and oversight that sustained health genuinely warrants.

References

Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930.

Rosen CJ, Abrams SA, Aloia JF, et al. IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab. 2012;97(4):1146–1152.

Tripkovic L, Lambert H, Hart K, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr. 2012;95(6):1357–1364.

Cashman KD, Dowling KG, Škrabáková Z, et al. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr. 2016;103(4):1033–1044.

Bouillon R, Marcocci C, Carmeliet G, et al. Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocr Rev. 2019;40(4):1109–1151.

Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999;69(5):842–856.

National Academies of Sciences, Engineering, and Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Washington DC: National Academies Press; 2011.

US Preventive Services Task Force. Screening for vitamin D deficiency in adults: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(14):1436–1442.

Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583.

Lips P, van Schoor NM. The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab. 2011;25(4):585–591.